Moura Andre V. 4
4 · Bellerophon Therapeutics, Inc. · Filed Jun 7, 2018
Insider Transaction Report
Form 4
Moura Andre V.
Director
Transactions
- Award
Stock Option (right to buy)
2018-06-05$2.27/sh+38,216$86,750→ 58,216 totalExercise: $2.27From: 2019-06-05Exp: 2028-06-04→ Common Stock (38,216 underlying)